3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Conditions
Obesity
9
Endometrial Neoplasms
5
Prostatic Neoplasms
2
Overweight
2
Endometrial Hyperplasia
2
Diabetes Mellitus
2
Breast Neoplasms
2
Weight Loss
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polycystic Ovary Syndrome
1
Opioid-Related Disorders
1
Metabolic Syndrome
1
Lymphoma, Follicular
1
Insulin Resistance
1
Inflammation
1
Hyperplasia
1
Dyslipidemias
1
Colorectal Neoplasms
1
Interventions
Metformin
21
Inositol
13
Letrozole
9
Exercise
5
Surveys and Questionnaires
4
Clomiphene
4
Tablets
3
Estradiol
3
semaglutide
2
maltodextrin
2
drospirenone and ethinyl estradiol combination
2
Spironolactone
2
Progesterone
2
Ethinyl Estradiol
2
Diet Therapy
2
Contraceptives, Oral, Combined
2
Caloric Restriction
2
Acupuncture Therapy
2
salicylsalicylic acid
1
mirabegron
1
etonogestrel
1
drospirenone
1
dapagliflozin
1
cetrorelix
1
Walking
1
Tirzepatide
1
Thyroxine
1
Thioctic Acid
1
Tamoxifen
1
Sodium-Glucose Transporter 2 Inhibitors
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Polycystic Ovary Syndrome
×
Tirzepatide
×
1 year
×
Clear all
NCT07326111
2026-01-08
PERIODS
University of Bonn
Phase 4
Recruiting
198 enrolled